Drugs / AK1320 MS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04483297 | Nov 2020 → Nov 2023 | spinal stenosis, spondylolisthesis | Asahi Kasei Therapeutics Corporation | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AK1320 MS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04483297 ↗ |